NCI Cancer Research Education Grants Program
The Cancer Research Education Grants Program (R25) supports innovative, evidence-based educational activities that enhance the training of biomedical, behavioral, and clinical researchers in the field of cancer. There are three distinct funding opportunities within this program, each targeting a different educational goal: curriculum development, short-term courses for skill-building, and hands-on cancer research experiences. These initiatives aim to strengthen the pipeline of researchers equipped to tackle cancer-related challenges through high-impact education.
Eligibility Criteria
- Principal Investigator must be at or above the rank of Associate Professor (or equivalent)
- U.S. citizens and non-citizens are eligible if employed by an eligible U.S. institution
- R25 projects may include international participants, with justification
- R25 programs must be education-focused and cannot support formal training or degree programs
- Institutional and participant eligibility requirements vary by NOFO (see below)
Funding Opportunities and Budget Details
- PAR-23-278 (Curriculum or Methods Development):
- Up to 150,000 USD direct costs per year for up to 2 years
- Focus: Development of new educational curricula or methods
- Cannot fund direct teaching of curriculum
- PAR-23-276 (Courses for Skills Development):
- Up to 300,000 USD direct costs per year for up to 5 years
- Focus: Annual offering of state-of-the-art, cancer-focused skills development courses
- PAR-23-277 (Research Experiences):
- Up to 300,000 USD direct costs per year for up to 5 years
- Focus: 8–15 week full-time research experiences, plus additional part-time continuation (up to 12 months)
- Can include complementary activities (journal clubs, seminars, etc.) up to 20% of time
Application Deadlines
- January 25, May 25, September 25 (annually)
- Applications are due by 5:00 PM local time
- If the date falls on a weekend/holiday, submission is due the next business day
- Earliest start dates: April, July, or December depending on cycle
Further Information
Applications must follow the SF424(R&R) guidelines and be submitted electronically via Grants.gov or eRA Commons. Review full details, FAQs, and program contacts via the NCI R25 Program Page or contact the program officer listed in the NOFO.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023